Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
489 total articles
Teresa Brophy Bair, Kura Oncology's chief legal officer, sold 11,208 shares on January 27, 2026 to satisfy tax obligations tied to prior RSU grants. The company also reported its first U.S. commercial sale of KOMZIFTI, triggering a $135 million payment from Kyowa Kirin expected before the end of 2025. Citizens reaffirmed its Market Outperform ratin…
Protagonist Therapeutics' Chief Medical Officer, Arturo Molina MD, sold 23,151 shares across three trades late January 2026 for about $1.9 million and exercised 10,000 options. The transactions were disclosed in a Form 4 filing and come amid a string of analyst price-target increases and maintained Buy/Outperform ratings tied to upcoming regulatory…
Thomas James Doyle, Kura Oncology's senior vice president of finance and accounting, sold 7,141 shares on January 27, 2026, realizing $60,426. The sale was completed to satisfy tax obligations tied to vested restricted stock units. The company has reported recent commercial progress with KOMZIFTI and retains positive analyst coverage while remainin…
Kura Oncology Chief Operating Officer Kathleen Ford sold 1,813 shares on January 27, 2026, to satisfy tax obligations tied to a 2022 restricted stock unit award. The transaction followed a sequence of corporate milestones for Kura, including the first U.S. commercial sale of KOMZIFTI, a $135 million milestone payment from partner Kyowa Kirin expect…
Mollie Leoni, chief medical officer at Kura Oncology, executed four stock sales on January 27, 2026, disposing of 8,182 shares for roughly $69,208 to meet tax liabilities from vested restricted stock units. The transactions occurred while Kura shares traded near $8.47, a level InvestingPro indicates sits below the stock's Fair Value despite a 36.72…
Kura Oncology Chief Scientific Officer Francis Burrows sold 1,311 shares on Jan. 27, 2026, at $8.4607 per share to satisfy tax obligations tied to an RSU vesting. The company meanwhile reported its first U.S. commercial sale of KOMZIFTI, triggering a $135 million milestone payment from partner Kyowa Kirin expected before the end of 2025.
Eric Sprott and an entity he controls purchased 100,000 Hycroft Mining Class A shares at $49.96 apiece on January 26, 2026, a $4,996,000 investment that raises his total holdings to 36,553,704 shares. The company has reported exceptional silver drill results at its Vortex system, eliminated all debt after raising $235 million in net proceeds, and c…
MDB Capital Holdings, LLC (NASDAQ: MDBH) reported two insider sales by Chief Financial Officer James Jeremy William on January 23 and January 26, 2026. The transactions, executed as sell-to-cover trades to satisfy tax withholding obligations from restricted stock vesting, totaled $11,621 and reduced William's direct stake to 19,839 shares. The comp…
Charles E Jobson, who holds a roughly 10% stake in The Joint Corp (NASDAQ: JYNT), bought 17,478 shares of the company in two SEC-reported transactions, spending $174,780 at $10.00 per share. The purchases came as the small-cap operator shows a stronger cash position than debt, posted an earnings beat in Q3 2025, and entered into an agreement to div…
Sheena Jonathan, co-founder of Natera, sold $365,914 of company shares on January 23, 2026, under a pre-arranged trading plan. The transactions involved shares held by Caraluna 1 Trust and Caraluna 2 Trust at prices between $242.232 and $245.62 per share. Separately, Natera reported preliminary fourth-quarter 2025 results showing near 40% revenue g…
Travere Therapeutics CEO Eric M. Dube sold 60,000 shares of common stock across transactions on January 23 and January 27, 2026, under a pre-arranged 10b5-1 program, generating roughly $1.8 million in proceeds. On the same dates he exercised options to acquire 60,000 shares at $15.46 each. Separately, the FDA has extended the review of Travere's su…
Intel Executive Vice President and Chief Financial Officer David Zinsner acquired 5,882 shares of Intel common stock on January 26, 2026, for $42.50 per share, a transaction valued at $249,985, according to a Form 4 filed with the Securities and Exchange Commission. The purchase follows recent volatility in Intel's stock and comes alongside quarter…
Adobe Inc. Executive Vice President and Chief Financial Officer Daniel Durn sold 1,646 shares on January 27, 2026, for $294.8501 per share, a transaction valued at $485,323. The sale was disclosed in a Form 4 filing that also shows Durn exercised options and satisfied tax obligations tied to a larger award of shares. The trades come as Adobe shares…
Kenneth Ahn, president of Hagerty Marketplace, executed a pre-arranged sale of 50,000 Class A shares on January 26, 2026 for $620,500 at prices between $12.30 and $12.67. The transaction, carried out under a Rule 10b5-1 plan adopted September 15, 2025, coincided with Ahn acquiring 50,000 Class A shares via conversion of Hagerty Group units at no co…
A director of the John Hancock Financial Opportunities Fund purchased $10,001 worth of the fund's shares on January 26, 2026, while John Hancock confirmed renewed share repurchase plans for six of its closed-end funds for the 2026 calendar year. The fund carries a double-digit-looking yield and favorable metrics reported by InvestingPro.
Sera Prognostics Chief Information Officer Harrison Robert Gardner sold 2,000 shares of Class A common stock on January 27, 2026, at a weighted average price of $2.97 for total proceeds of $5,940. The trade was executed under a Rule 10b5-1 trading plan adopted May 21, 2025. Separately, Sera reported Q3 2025 results showing an EPS of -$0.16, outperf…
Director Christopher D. Maggiore bought 1,766 shares of Zivo Bioscience Inc. (NASDAQ: ZIVO) on January 14, 2026, paying $8.49 per share for a $14,993 transaction. After the purchase Maggiore holds 519,292 shares directly. The company, with a $38.52 million market capitalization, has seen its stock rise 16.77% over the past week, and InvestingPro da…
SLB LIMITED/NV (NYSE: SLB) Chief Accounting Officer Howard Guild sold 13,268 shares on January 26, 2026 for $659,419 while also recording other related equity movements tied to performance share vesting. The stock has risen to $50.66 and trades near its 52-week high amid a wave of analyst target revisions following better-than-expected fourth-quart…
SLB Limited/NV Executive Vice President and Chief Financial Officer Stéphane Biguet sold 61,017 shares of common stock on January 26, 2026, at $49.70 per share for gross proceeds of $3,032,544, according to a Form 4 filing. Earlier in the week Biguet received 51,885 performance shares that vested upon meeting specified criteria and also sold 20,418…
Assured Guaranty Ltd and affiliated entities reported two insider sales of Sound Point Meridian Capital, Inc. (NASDAQ: SPMC) common stock on January 23 and January 27, 2026, totaling $69,623. The transactions, executed at per-share prices between $14.2917 and $14.3061, reduced the reporting parties' indirect holdings to 5,269,690 shares. Separately…
Dianne B. Ralston, SLB's Chief Legal Officer and Secretary, reported a sale of 18,617 shares on January 26, 2026 for $49.50 per share, valued at $921,541. The Form 4 filing also shows a separate disposition of 17,667 shares to cover tax obligations at $50.25, and the vesting-related acquisition of 47,437 shares on January 23, 2026 tied to performan…
Northern Trust Corp's Chief Operating Officer, Peter Cherecwich, sold 25,000 shares of common stock on January 26, 2026, for roughly $3.74 million. The transaction came amid a backdrop of robust fourth-quarter 2025 results that topped analyst expectations and prompted several price-target increases from major brokerages. The firm continues to trade…
Merad Abdellah, Executive Vice President of Core Services & Equipment at SLB Limited (NYSE:SLB), sold 60,000 shares on January 26, 2026, for about $2.98 million. Earlier that week he received 51,885 shares from the vesting of performance share units and sold 20,418 shares on January 23, 2026, to cover tax obligations. SLB’s recent fourth-quarter 20…
Symbotic Inc.'s Chief Technology Officer, James Kuffner, sold $4.6 million worth of Class A common stock on January 26, 2026, after exercising options earlier in the week. The transactions accompany a company stock offering and a downgrade from Goldman Sachs, while InvestingPro data highlights strong revenue growth and a cash-rich balance sheet.
Wayfair Chief Executive Niraj Shah sold 150,600 shares of Class A common stock on January 23, 2026, for roughly $16.3 million across three trades executed under a pre-arranged Rule 10b5-1 plan. The stock has rallied 125% over the past year and is trading above its Fair Value, according to InvestingPro data, while analysts express divergent views an…
